Table 3 Prognostic indicators of overall survival using multivariate analysis
From: Negative impact of low body mass index on liver cirrhosis patients with hepatocellular carcinoma
Variables | Exp(B) | 95 % confidence interval | p |
|---|---|---|---|
Age | 1.123 | 0.876–1.439 | 0.360 |
AFP | 1.123 | 0.836–1.508 | 0.443 |
Child–Pugh stage | 2.187 | 1.567–3.052 | 4.2 × 10−6 |
Treatment strategy | 3.193 | 1.748–5.832 | 1.6 × 10−4 |
Portal invasion | 0.772 | 0.535–1.112 | 0.164 |
BMI class | 0.347 | 0.239–0.502 | 2.2 × 10−8 |
Extrahepatic metastasis | 2.154 | 1.412–3.287 | 3.7 × 10−4 |
Antiviral treatment | 1.330 | 0.942–1.878 | 0.105 |